Similarly, in breast cancer models, tamoxifen induces nuclear translocation of the PRMT5/MEP50 methylosome complex, where it catalyzes ERα methylation and promotes the recruitment of corepressors, such as SMRT and HDAC1, leading to the suppression of ERα transcriptional activity (7). The gene discussed is ESR1; the disease is breast carcinoma.